Abstract:Abstract Despite atrial fibrillation (AF) being a common, clinically important, and economically significant public health problem, the initiation mechanisms of atrial remodeling during AF is still unclear. Furthermore, really few experimental models have the power to investigate these mechanisms in a human invitro two-dimensional (2D) monolayer of atrial cardiomyocytes. The purpose of this work is to use human induced pluripotent stem cell (hiPSC)-derived atrial cardiomyocytes to develop a new human in vitro atrial model of AF able to reproduce and evaluate the arrhythmia initiation and maintenance mechanisms. Two different hiPSC lines were differentiated into atrial cardiomyocytes using 1 μM retinoic acid from day 3 to day 8. Protocol to differentiate atrial cells was compared with the classical method to generate ventricular hiPSC to demonstrate atrial specificity. On day 20 of the differentiation cells were seeded into plates with different sizes: 0.32 cm2 and 9.6 cm2, a larger size that allows rotor formation. After 10 days qPCR and optical mapping experiments were performed at 37 ̊C. These experiments aimed to evaluate the electrophysiologic and genetic remodeling the Cells undergo during AF initiation and maintenance. The atrial phenotype was assessed by patch clamp recordings that showed cells treated with RA had significantly shorter action potential duration at 90% repolarization compared to the no RA treated, 182.3.5 ± 68 ms and 371.6 ± 82 ms, faster depolarization rate and higher spontaneous beating frequency (n=14, ± SD). Optical mapping experiments allowed the evaluation of activation rate depending on the size of the dish: larger wells activated spontaneously at 1.6 ± 1.9 Hz, whereas smaller wells presented 0.9 ± 0.5 Hz of activation rate. The fast activation rate on larger wells was associated higher number of reentrant wavefronts: 11.0 ± 8.2 reentries/cm2, vs 0.9 ± 0.5 reentries/cm2 in the smaller wells, demonstrating an AF phenotype. In fact, depending on the culture conditions cells showed different reentries occurrence: 100% of large dishes exhibited fibrillation compared to only 10% of small dishes. Furthermore, qPCR studies demonstrated that the spontaneous initiation and maintenance of rotors in the larger well sizes lead to an expression remodeling of the channels SCN5A, KCNJ2, GJA5, ATP2A2, and RYR2 as previously demonstrated on isolated tissue from AF patients. We conclude that atrial cardiomyocytes obtained from hiPSC can recapitulate the remodeling that atrial tissue undergoes during AF initiation in patients. Providing a unique opportunity to study the initiation of fibrillatory activities and their maintenance in a human-relevant in-vitro model.hiPSC-aCM characterizationElectrophysiologic & genetic remodeling

Abstract 272: Pharmacological Testing Of Novel Atrial-specific Ion Channel Blockers Establishes Human Pluripotent Stem Cell Derived Atrial Cardiomyocytes As A Predictive Pre-clinical Model For Selective Pharmacology

Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Differentiation and Characterization of Rhesus Monkey Atrial and Ventricular Cardiomyocytes from Induced Pluripotent Stem Cells.

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

Improved Atrial Differentiation of Human Pluripotent Stem Cells by Activation of Retinoic Acid Receptor Alpha (RARα)

In vitro model of atrial fibrillation: investigating the initiation and maintenance mechanisms of atrial remodeling using hiPSC-derived atrial cardiomyocytes

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation

Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

High-Throughput Drug Screening System Based on Human Induced Pluripotent Stem Cell-Derived Atrial Myocytes ∼ A Novel Platform to Detect Cardiac Toxicity for Atrial Arrhythmias

Atrial hiPSC-CM as a pharmacological model to evaluate anti-AF drugs: Some lessons from IKur

Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation

Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development

Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists

Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue

Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation

Abstract P1031: An Optogenetic Approach To Study Atrial-fibrillation-associated Remodelling In Atrial Engineered Human Myocardium

In situ monolayer patch clamp of acutely stimulated human iPSC-derived cardiomyocytes promotes consistent electrophysiological responses to SK channel inhibition

Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC–derived atrial fibrillation model